As federal agencies begin to receive American Recovery and Reinvestment Act (ARRA) funds (see IBO 2/28/09)—the so-called US stimulus funding—they are releasing more information about how they plan to spend the money. Of all of the agencies, the NIH was the largest beneficiary (see IBO 2/28/09) of ARRA funds for research. This article will outline […]
The IBO Laboratory Sales Index has been updated from the February 15 issue now that 19 of the 21 companies in the Index have reported calendar-year 2008 results. Estimates are provided for Oxford Instruments and Shimadzu. For the fourth quarter, Laboratory Sales Index revenues improved 1.1% to $4,715 million. Operating profits grew 2.4%, and operating […]
Fourth-quarter sales for the Lab Equipment/Consumables Sales Index declined 1.2% to $866.20 million, while operating profits improved 5.6% to $265.08 million. Operating margins rose 200 basis points to 30.6% of sales due to cost savings initiatives by a majority of companies in the Index. For the year, Index sales improved 7.5% to $3,557.89 million, operating […]
This year is shaping up to be a big one for Restek. In January, the company, which has provided chromatography columns and accessories since 1985, became 100% employee owned. Restek now runs under an employee stock ownership program. In February, Restek opened its first Asian office in Tokyo, Japan. Due to the change in ownership, […]
Since last fall, labs worldwide have struggled to cope with a shortage of acetonitrile (ACN), the most commonly used organic solvent for LC mobile phase. Companies supplying LC products have responded with information, support and solutions for end-users looking to conserve the now precious chemical compound, for which prices have skyrocketed. ACN suppliers’ measures have […]
On March 11, the US Omnibus Appropriations Act of 2009 became law, funding 12 federal agencies for which Congress had not passed a budget for the fiscal year that started on October 1, 2008. Since last fall, these agencies had been funded under a continuing extension (see IBO 10/15/08). According to the American Association for […]
In calendar year 2008, Thermo Fisher Scientific retained its position as the number one provider of analytical and life science instruments and aftermarket products, according to IBO’s annual calculation of the top 30 companies. The top 30 companies generated an estimated $26.6 billion in sales of analytical and life science instruments and aftermarket products last […]
The first of IBO’s biannual new laboratory roundup focuses on the Middle East and food testing in Asia. Despite the drop in the price of oil, oil money continues to stimulate new lab growth in the Middle East. The establishment of food safety testing laboratories in Asia is a high priority for independent testing laboratories, […]
Atomic Spectroscopy Bruker’s S8 Lion is a high-end simultaneous wavelength dispersive (WD)-X-ray fluorescence spectroscopy (XRF) system with up to 16 detectors. The system is easy to use through a flat touchscreen interface. The system is now available at a price of $220,000. Bruker’s M Series of XRF analyzers provides microspot XRF. The M1 Ora is […]
The US markets experienced another volatile month in March, but managed to ignite a sharp recovery after reaching new lows on March 9. The Dow Jones Industrial Average, S&P 500 and NASDAQ finished the month up 7.7%, 8.5% and 10.9%, respectively. Investor sentiment turned cautiously optimistic following a report that Citigroup recorded a significant operating […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
